Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
X-linked adrenoleukodystrophy (X-ALD) is a fatal neurodegenerative disorder, characterized by progressive cerebral demyelination cerebral childhood adrenoleukodystrophy (CCALD) or spinal cord neurodegeneration (adrenomyeloneuropathy, AMN), adrenal insufficiency and accumulation of very long-chain fatty acids (VLCFA) in tissues. The disease is caused by mutations in the ABCD1 gene, which encodes a peroxisomal transporter that plays a role in the import of VLCFA or VLCFA-CoA into peroxisomes. The Abcd1 knockout mice develop a spinal cord disease that mimics AMN in adult patients, with late onset at 20 months of age. The mechanisms underlying cerebral demyelination or axonal degeneration in spinal cord are unknown. Here, we present evidence by gas chromatography/mass spectrometry that malonaldehyde-lysine, a consequence of lipoxidative damage to proteins, accumulates in the spinal cord of Abcd1 knockout mice as early as 3.5 months of age. At 12 months, Abcd1- mice accumulate additional proteins modified by oxidative damage arising from metal-catalyzed oxidation and glycoxidation/lipoxidation. While we show that VLCFA excess activates enzymatic antioxidant defenses at the protein expression levels, both in neural tissue, in ex vivo organotypic spinal cord slices from Abcd1- mice, and in human ALD fibroblasts, we also demonstrate that the loss of Abcd1 gene function hampers oxidative stress homeostasis. We find that the alpha-tocopherol analog Trolox is able to reverse oxidative lesions in vitro, thus providing therapeutic hope. These results pave the way for the identification of therapeutic targets that could reverse the deregulated response to oxidative stress in X-ALD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, supraphysiological accumulation of C26:0 in astrocytes of ABCD1-deficient mice is followed by production of high reactive oxygen species (15, 16).”
From X-linked adrenoleukodystrophy and primary adrenal insufficiency (2023) · cites this paper as [15]
In the citing paper
“Interestingly, Abcd1 knockout mice display oxidative damage to proteins in the spinal cord already at the age of 3 months [39], long before the first neuropathological lesions in the spinal cord at around 16 months of age and clinical signs at 20 months of age [40].”
From X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects (2012) · cites this paper as [39]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“Oxidative stress is a common finding to a growing number of neurodegenerative diseases, although its role as causative factor needs still to be ascertained for most of them (12).”
BackgroundWang, H., & Joseph, J. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00107-0 · Cited by 2,346 · cited 2×
“Intracellular ROS levels were estimated using the ROSsensitive H2DCFDA probe as described (27,61).”
MethodHalliwell, B., & Whiteman, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705776 · Cited by 2,238
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623 · cited 1×
“It is tempting to speculate about a scenario comparable with ALS, in which different cell types contribute to different phases of disease progression—motorneurons in early phases of disease onset and microglia in later phases (44).”
ResultInoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577 · cited 1×
“Indeed, a few examples of fatty acids producing ROS via extramitochondrial sources include: (i) the saturated palmitic acid involving activation of NAD(P)H oxidase (47); (ii) arachidonic acid conversion via lipoxygenase (48,49); (iii) the degradation of VLCFA in peroxisomes, which could account for a part of observed…”
BackgroundLocalization of mitochondria in living cells with rhodamine 123.
Johnson, L. V., Walsh, M. L., & Chen, L. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.2.990 · Cited by 1,553
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202 · cited 2×
“The disease is caused by mutations in the ALD gene (official nomenclature ABCD1) that lead to loss of function of the ALD protein (ALDP) (2).”
BackgroundVivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
Mitochondrial Membrane Potential in Living Cells
Chen, L. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.001103 · Cited by 1,037 · cited 1×
“takes benefit of the differential membrane potential to get selectively accumulated in mitochondria (29).”
BackgroundUncoupling: new approaches to an old problem of bioenergetics
Skulachev, V. P. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(97)00091-1 · Cited by 893 · cited 1×
“Usually, such mild reduction in DC in mitochondria is not associated to increased ROS production but the opposite (46), thus suggesting that extra-mitochondrial sources of enhanced ROS production are more likely to be activated in response to VLCFA.”
BackgroundFu, M.-X., Requena, J. R., Jenkins, A. J., Lyons, T. J., Baynes, J. W., & Thorpe, S. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9982 · Cited by 822 · cited 1×
“The following isotopically labeled internal standards were then added: [(2)H8]lysine (d8-Lys; CDN isotopes); [(2)H4]CML (d4-CML), [ (2)H4]CEL (d4-CEL) and [(2)H8]MDAL (d8-MDAL), prepared as described (22,64); and [(2)H5]5-hydroxy-2-aminovaleric acid (for GSA quantization) and [(2)H4]6-hydroxy-2-aminocaproic acid (for…”
MethodMoser, H. W., Mahmood, A., & Raymond, G. V. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0421 · Cited by 663
Oxygen radical mechanisms of brain injury following ischemia and reperfusion
Traystman, R. J., Kirsch, J. R., & Koehler, R. C. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.71.4.1185 · Cited by 653 · cited 1×
“Indeed, a few examples of fatty acids producing ROS via extramitochondrial sources include: (i) the saturated palmitic acid involving activation of NAD(P)H oxidase (47); (ii) arachidonic acid conversion via lipoxygenase (48,49); (iii) the degradation of VLCFA in peroxisomes, which could account for a part of observed…”
BackgroundChronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
Rothstein, J. D., Jin, L., Dykes-Hoberg, M., & Kuncl, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6591 · Cited by 623 · cited 10×
“Organotypic spinal cord slice culture (OSCSC) The spinal cords from 18-day-old mice were immediately removed and placed in ice-cold dissecting media (pH 7.15).”
MethodInfluentialVitamin E and its function in membranes
Wang, X. (1999) · Progress in Lipid Research · doi:10.1016/s0163-7827(99)00008-9 · Cited by 559 · cited 1×
“a-Tocopherol is a wellknown lipid antioxidant whose preferential site of action is within cell membranes, forming complexes with free saturated and unsaturated fatty acids and therefore neutralizing the detergent-like properties of the hydrolytic products that would otherwise disrupt membrane stability (34,35).”
BackgroundMaillard reaction products in tissue proteins: New products and new perspectives
Thorpe, S. R., & Baynes, J. W. (2003) · Amino Acids · doi:10.1007/s00726-003-0017-9 · Cited by 543 · cited 15×
“The following isotopically labeled internal standards were then added: [2H8]lysine (d8-Lys; CDN isotopes); [2H4]CML (d4-CML), [ 2H4]CEL (d4-CEL) and [2H8]MDAL (d8-MDAL), prepared as described (22,64); and [2H5]5-hydroxy-2-aminovaleric acid (for GSA quantization) and [2H4]6-hydroxy-2-aminocaproic acid (for AASA quantiz…”
BackgroundInfluentialRequena, J. R., Chao, C.-C., Levine, R. L., & Stadtman, E. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.69 · Cited by 415 · cited 3×
“The N,O-trifluoroacetyl methyl ester derivatives of the protein hydrolysate were prepared as described previously (20).”
MethodEffect of fatty acids on energy coupling processes in mitochondria
Wojtczak, L., & Schönfeld, P. (1993) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(93)90004-y · Cited by 363 · cited 1×
“Free long-chain fatty acids have been reported to produce ROS by blocking the electron transport chain and modifying mitochondrial inner membrane potential (DC) by acting as protonophores (28).”
BackgroundOxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis
Ilieva, E. V., Ayala, V., Jove, M., Dalfo, E., Cacabelos, D., Povedano, M., Bellmunt, M. J., Ferrer, I., Pamplona, R., & Portero-Otin, M. (2007) · Brain · doi:10.1093/brain/awm190 · Cited by 358
Self-citationAxonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes
Kassmann, C. M., Lappe-Siefke, C., Baes, M., Brügger, B., Mildner, A., Werner, H. B., Natt, O., Michaelis, T., Prinz, M., Frahm, J., et al. (2007) · Nature Genetics · doi:10.1038/ng2070 · Cited by 357 · cited 1×
“However, since impairment of peroxisomal functions in oligodendrocytes can result in demyelination or axonal damage (43), this possibility remains open.”
BackgroundHettema, E. H., van Roermund, C. W., Distel, B., van den Berg, M., Vilela, C., Rodrigues‐Pousada, C., Wanders, R. J., & Tabak, H. F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00755.x · Cited by 323 · cited 1×
“ALDP is an half ATP-binding cassette (ABC) transporter, an integral peroxisomal membrane protein whose putative role is the transport of VLCFA or VLCFA–CoA esters into the peroxisome for degradation by b-oxidation, by analogy to its yeast homologs Pxa1p and Pxa2p (3).”
BackgroundKemp, S., Pujol, A., Waterham, H. R., van Geel, B. M., Boehm, C. D., Raymond, G. V., Cutting, G. R., Wanders, R. J. A., & Moser, H. W. (2001) · Human Mutation · doi:10.1002/humu.1227 · Cited by 321 · cited 1×
“The most divergent clinical phenotypes can occur within the same family; thus, there is no phenotype–genotype correlation (4), what suggests the existence of modifier genes.”
BackgroundSelf-citationUpston, J. M., Terentis, A. C., & Stocker, R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.977 · Cited by 300
REQUENA, J. R., FU, M. X., AHMED, M. U., JENKINS, A. J., LYONS, T. J., BAYNES, J. W., & THORPE, S. R. (1997) · Biochemical Journal · doi:10.1042/bj3220317 · Cited by 293 · cited 15×
“The following isotopically labeled internal standards were then added: [2H8]lysine (d8-Lys; CDN isotopes); [2H4]CML (d4-CML), [ 2H4]CEL (d4-CEL) and [2H8]MDAL (d8-MDAL), prepared as described (22,64); and [2H5]5-hydroxy-2-aminovaleric acid (for GSA quantization) and [2H4]6-hydroxy-2-aminocaproic acid (for AASA quantiz…”
BackgroundMethodInfluentialA mouse model for X-linked adrenoleukodystrophy
Lu, J.-F., Lawler, A. M., Watkins, P. A., Powers, J. M., Moser, A. B., Moser, H. W., & Smith, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9366 · Cited by 293 · cited 1×
“The generation and genotyping of Abcd1(2) mice have been previously described (6,60).”
MethodProteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and Lipoxidation
Pamplona, R., Dalfó, E., Ayala, V., Bellmunt, M. J., Prat, J., Ferrer, I., & Portero-Otín, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502255200 · Cited by 280 · cited 7×
“GC/MS analyses were carried out on a Hewlett-Packard model 6890 gas chromatograph equipped with a 30-m HP-5MS capillary column (30 m 0.25 mm 0.25 mm) coupled to a Hewlett-Packard model 5973A mass selective detector (Agilent, Barcelona, Spain).”
MethodInfluentialSelf-citationReactive oxygen species: production and role in the kidney
Baud, L., & Ardaillou, R. (1986) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1986.251.5.f765 · Cited by 267 · cited 1×
“Indeed, a few examples of fatty acids producing ROS via extramitochondrial sources include: (i) the saturated palmitic acid involving activation of NAD(P)H oxidase (47); (ii) arachidonic acid conversion via lipoxygenase (48,49); (iii) the degradation of VLCFA in peroxisomes, which could account for a part of observed…”
BackgroundEvidence of Oxidative Stress in the Neocortex in Incidental Lewy Body Disease
Dalfó, E., Portero-Otín, M., Ayala, V., Martínez, A., Pamplona, R., & Ferrer, I. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000179050.54522.5a · Cited by 261
Self-citationMitochondrial oxidative stress, aging and caloric restriction: The protein and methionine connection
Pamplona, R., & Barja, G. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.01.009 · Cited by 257 · cited 1×
“The different types of observed protein oxidative damage and the induction of antioxidant response suggest that in X-ALD general mechanisms triggering oxidative stress, such as free radical production, could take place (26).”
BackgroundSelf-citationGenetic clues to the pathogenesis of Parkinson's disease
Vila, M., & Przedborski, S. (2004) · Nature Medicine · doi:10.1038/nm1068 · Cited by 255 · cited 2×
“with few exceptions, such as the SOD1 mouse, a model of ALS (41), and the toxic models, for instance the induction of Parkinson through treatment with the mitochondrial toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (42).”
BackgroundKühn, H., & Borchert, A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00855-9 · Cited by 253 · cited 1×
“Taken together, our data suggests that impairment GSH homeostasis could be instrumental in X-ALD pathogenesis, as GSH acts as a co-factor in the reduction of ROS and lipid hydroperoxides (54,55).”
BackgroundWanders, R. J. A., Vreken, P., Ferdinandusse, S., Jansen, G. A., Waterham, H. R., van Roermund, C. W. T., & Van Grunsven, E. G. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290250 · Cited by 225
Pujol, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.499 · Cited by 214 · cited 5×
“The generation and genotyping of Abcd1(2) mice have been previously described (6,60).”
BackgroundMethodInfluentialSelf-citationChapter 14 Measurement of Cell Death
Loo, D. T., & Rillema, J. R. (1998) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)61583-6 · Cited by 205 · cited 1×
“Cell death was quantified by measuring the levels of lactate dehydrogenase (LDH) activity, an enzyme released in the medium by damaged membranes (33).”
MethodPujol, A., Ferrer, I., Camps, C., Metzger, E., Hindelang, C., Callizot, N., Ruiz, M., Pàmpols, T., Giròs, M., & Mandel, J. L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh323 · Cited by 201 · cited 6×
“5 and 17 months of age, after perfusion with PFA4% basically as described (5,52).”
BackgroundMethodInfluentialSelf-citationNeurotoxicity of organomercurial compounds
Sanfeliu, C., Sebastià, J., Cristòfol, R., & Rodríguez-Farré, E. (2003) · Neurotoxicity Research · doi:10.1007/bf03033386 · Cited by 199 · cited 1×
“The intracellular content of GSH was determined using monochlorobimane, a thiol-reactive probe (62).”
MethodWhitcomb, R. W., Linehan, W. M., & Knazek, R. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113292 · Cited by 168 · cited 4×
“ALD cells have been reported to have an increase in membrane microviscosity (8), produced by C26:0 and accounting for a defective response to trophic factors in adrenocortical cells (9).”
BackgroundMethodInfluentialDepletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo
Chi, L., Ke, Y., Luo, C., Gozal, D., & Liu, R. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.064 · Cited by 167 · cited 13×
“The tripeptide glutathione (g-L-glutamyl-L-cysteinylglycine or GSH) is the most abundant and important nonprotein thiol in mammalian cells, reaching concentrations up to 10 mM in the cytoplasm and about 1 mM in blood (30).”
MethodInfluentialSchönfeld, P., & Wojtczak, L. (2007) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2007.04.005 · Cited by 164 · cited 1×
“Long-chain fatty acids have been shown to produce ROS through inhibition of the mitochondria respiratory chain and a change in membrane fluidity, at least in purified mitochondria (45).”
BackgroundLipid peroxidation in neurodegeneration: new insights into Alzheimerʼs disease
Arlt, S., Beisiegel, U., & Kontush, A. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00009 · Cited by 151 · cited 1×
“The high content of the highly peroxidizable polyunsaturated fatty acids in brain membranes, the elevated oxygen consumption and the relatively poor expression of enzymatic antioxidant defenses in nervous system support the high susceptibility of these organs to oxidative damage (13).”
BackgroundRole of ALDP (ABCD1) and Mitochondria in X-Linked Adrenoleukodystrophy
McGuinness, M. C., Lu, J.-F., Zhang, H.-P., Dong, G.-X., Heinzer, A. K., Watkins, P. A., Powers, J., & Smith, K. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.744-753.2003 · Cited by 147 · cited 1×
“Indeed, ultrastructural alterations have been found in X-ALD mitochondria from spinal cords and adrenocortical cells (52,53), warranting a careful assessment of mitochondria functionality.”
BackgroundAnti‐atherosclerotic effects of vitamin E – myth or reality?
Munteanu, A., Zingg, J. ‐., & Azzi, A. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00260.x · Cited by 145
Erin, A. N., Spirin, M. M., Tabidze, L. V., & Kagan, V. E. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90279-7 · Cited by 142 · cited 1×
“a-Tocopherol is a wellknown lipid antioxidant whose preferential site of action is within cell membranes, forming complexes with free saturated and unsaturated fatty acids and therefore neutralizing the detergent-like properties of the hydrolytic products that would otherwise disrupt membrane stability (34,35).”
BackgroundAdreno-leukodystrophy: Oxidative Stress of Mice and Men
Powers, J. M., Pei, Z., Heinzer, A. K., Deering, R., Moser, A. B., Moser, H. W., Watkins, P. A., & Smith, K. D. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000190064.28559.a4 · Cited by 129 · cited 2×
“In X-ALD brain of patients, immunohistochemical evidences for oxidative stress and damage have been found, mainly resulting from lipid peroxidation and mostly occurring in the inflammatory demyelinative lesions of ALD or AMN/ALD, as well as in adrenal cortex (17,18).”
BackgroundPaintlia, A. S., Gilg, A. G., Khan, M., Singh, A. K., Barbosa, E., & Singh, I. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.013 · Cited by 120 · cited 1×
“We incubated the slices with doses of 10–100 mM, taking into account that concentrations in patients can vary between 5 (in plasma (9)) and 60 mM (in brain demyelinating plaques (25)).”
MethodEvidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy
Vargas, C. R., Wajner, M., Sirtori, L. R., Goulart, L. D. S., Chiochetta, M., Coelho, D. M., Latini, A., Llesuy, S., Belló‐Klein, A., Giugliani, R., et al. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.10.004 · Cited by 118 · cited 2×
“Indeed, in X-ALD patients’ plasma and fibroblasts, indications for lipid peroxidation (by TBA-RS) and decrease of non-enzymatic antioxidant systems have been found (14,15).”
BackgroundResultFerrer, I., Kapfhammer, J. P., Hindelang, C., Kemp, S., Troffer-Charlier, N., Broccoli, V., Callyzot, N., Mooyer, P., Selhorst, J., Vreken, P., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi384 · Cited by 106 · cited 2×
“5 and 17 months of age, after perfusion with PFA4% basically as described (5,52).”
BackgroundMethodSelf-citationRotenone-like Action of the Branched-chain Phytanic Acid Induces Oxidative Stress in Mitochondria
Schönfeld, P., & Reiser, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513198200 · Cited by 103 · cited 1×
“As an alternative or additional etiopathogenic mechanism, we propose that VLCFA could generate oxidative stress as other fatty acids do (10,11).”
Background[9] Depletion of glutathione by inhibition of biosynthesis
Griffith, O. W. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(81)77011-3 · Cited by 98 · cited 13×
“The tripeptide glutathione (g-L-glutamyl-L-cysteinylglycine or GSH) is the most abundant and important nonprotein thiol in mammalian cells, reaching concentrations up to 10 mM in the cytoplasm and about 1 mM in blood (30).”
MethodInfluentialAn in vitro model of neurotrauma in organotypic spinal cord cultures from adult mice
Krassioukov, A. V., Ackery, A., Schwartz, G., Adamchik, Y., Liu, Y., & Fehlings, M. G. (2002) · Brain Research Protocols · doi:10.1016/s1385-299x(02)00180-0 · Cited by 95 · cited 10×
“Organotypic spinal cord slice culture (OSCSC) The spinal cords from 18-day-old mice were immediately removed and placed in ice-cold dissecting media (pH 7.15).”
MethodInfluentialRevisiting oxidative damage in ALS: microglia, Nox, and mutant SOD1
Boillée, S., & Cleveland, D. W. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34613 · Cited by 95 · cited 5×
“with few exceptions, such as the SOD1 mouse, a model of ALS (41), and the toxic models, for instance the induction of Parkinson through treatment with the mitochondrial toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (42).”
BackgroundInfluential[5] Detection of intracellular reactive oxygen species in cultured cells using fluorescent probes
Nègre‐Salvayre, A., Augè, N., Duval, C., Robbesyn, F., Thiers, J., Nazzal, D., Benoist, H., & Salvayre, R. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)52007-3 · Cited by 94 · cited 1×
“Intracellular ROS levels were estimated using the ROSsensitive H2DCFDA probe as described (27,61).”
MethodSelf-citationKnazek, R. A., Rizzo, W. B., Schulman, J. D., & Dave, J. R. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110963 · Cited by 94 · cited 2×
“ALD cells have been reported to have an increase in membrane microviscosity (8), produced by C26:0 and accounting for a defective response to trophic factors in adrenocortical cells (9).”
BackgroundAsheuer, M., Bieche, I., Laurendeau, I., Moser, A., Hainque, B., Vidaud, M., & Aubourg, P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi140 · Cited by 86 · cited 1×
“Also, there is no correlation between the ALD phenotype and the accumulation of VLCFA in plasma and fibroblasts from ALD patients, although a recent study suggests a link between the levels of VLCFA in white matter and disease severity (7).”
BackgroundNeužil, J., Weber, C., & Kontush, A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00741-3 · Cited by 77
PeroxisomeDB: a database for the peroxisomal proteome, functional genomics and disease
Schluter, A., Fourcade, S., Domenech-Estevez, E., Gabaldon, T., Huerta-Cepas, J., Berthommier, G., Ripp, R., Wanders, R. J. A., Poch, O., & Pujol, A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl935 · Cited by 74 · cited 1×
“Indeed, a few examples of fatty acids producing ROS via extramitochondrial sources include: (i) the saturated palmitic acid involving activation of NAD(P)H oxidase (47); (ii) arachidonic acid conversion via lipoxygenase (48,49); (iii) the degradation of VLCFA in peroxisomes, which could account for a part of observed…”
BackgroundSelf-citationRequena, J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011526698 · Cited by 67
Gilg, A. G., Singh, A. K., & Singh, I. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.12.1063 · Cited by 66 · cited 1×
“In X-ALD brain of patients, immunohistochemical evidences for oxidative stress and damage have been found, mainly resulting from lipid peroxidation and mostly occurring in the inflammatory demyelinative lesions of ALD or AMN/ALD, as well as in adrenal cortex (17,18).”
BackgroundMitochondrial Membrane Potential In Living Cells
Chen, L. (1988) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.4.1.155 · Cited by 61
Liddell, J. R., Dringen, R., Crack, P. J., & Robinson, S. R. (2006) · Glia · doi:10.1002/glia.20433 · Cited by 54
G�rtner, J. (2000) · Endocrine Development · doi:10.1159/000060840 · Cited by 49
Long-term stability of blood glutathione and cysteine in humans
Richie, J. P., Abraham, P., & Leutzinger, Y. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.7.1100 · Cited by 49 · cited 1×
“The tripeptide glutathione (g-L-glutamyl-L-cysteinylglycine or GSH) is the most abundant and important nonprotein thiol in mammalian cells, reaching concentrations up to 10 mM in the cytoplasm and about 1 mM in blood (30).”
BackgroundDeon, M., Sitta, A., Barschak, A. G., Coelho, D. M., Pigatto, M., Schmitt, G. O., Jardim, L. B., Giugliani, R., Wajner, M., & Vargas, C. R. (2007) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2007.08.008 · Cited by 43 · cited 2×
“Indeed, in X-ALD patients’ plasma and fibroblasts, indications for lipid peroxidation (by TBA-RS) and decrease of non-enzymatic antioxidant systems have been found (14,15).”
BackgroundResultDuval, C., Cámara, Y., Hondares, E., Sibille, B., & Villarroya, F. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.085 · Cited by 27 · cited 1×
“As an alternative or additional etiopathogenic mechanism, we propose that VLCFA could generate oxidative stress as other fatty acids do (10,11).”
BackgroundSelf-citationRadesäter, A., Johansson, S. M., Öberg, C., & Luthman, J. (2003) · Neurotoxicity Research · doi:10.1007/bf03033173 · Cited by 26 · cited 12×
“(A) Trolox prevents C26:0 dependent-induction of SOD2.”
BackgroundInfluentialPaintlia, A. S. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.012 · Cited by 2
Cited by
Engelen, M., Kemp, S., de Visser, M., van Geel, B. M., Wanders, R. J., Aubourg, P., & Poll-The, B. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-51 · Cited by 562
“In vivo, VLCFA cause oxidative stress and oxidative damage to proteins [64,65] microglial activation and apoptosis [66].”
Self-citationMyelin Proteomics: Molecular Anatomy of an Insulating Sheath
Jahn, O., Tenzer, S., & Werner, H. B. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8071-2 · Cited by 329
“Decreased plasmalogen levels [45, 46] and increased levels of reactive oxygen species [47, 48] may also contribute to the demyelination in X-linked adrenoleukodystrophy caused by the mutated peroxisomal transporter ABCD1, suggesting that a normal plasmalogen metabolism may prevent peroxisomal- and myelin-related disea…”
BackgroundX-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects
Kemp, S., Berger, J., & Aubourg, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.012 · Cited by 283
“play oxidative damage to proteins in the spinal cord already at the age of 3 months [39], long before the first neuropathological lesions”
Self-citationThe peroxisome: an update on mysteries 2.0
Islinger, M., Voelkl, A., Fahimi, H. D., & Schrader, M. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1722-5 · Cited by 283
The peroxisome: an update on mysteries
Islinger, M., Grille, S., Fahimi, H. D., & Schrader, M. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0941-4 · Cited by 281
“These were accompanied by increased oxidatively damaged proteins implying that the accumulating VLCFA induce increasing ROS concentrations potentially by modifying the mitochondrial inner membrane potential (Fourcade et al. 2008; Galino et al. 2011).”
Background
Metadata
- Authors
- Fourcade, S., Lopez-Erauskin, J., Galino, J., Duval, C., Naudi, A., Jove, M., Kemp, S., Villarroya, F., Ferrer, I., Pamplona, R., Portero-Otin, M., & Pujol, A.
- Affiliations
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Amsterdam UMC Location University of Amsterdam (NL)
- Instituto de Salud Carlos III (ES)
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Universitat de Lleida (ES)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Pujol, A.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-04
- Volume
- 17
- Issue
- 12
- Pages
- 1762-1773
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2168163415
- Cited by
- 214
- References
- 67
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 14 · 2023: 10 · 2022: 13 · 2021: 11 · 2020: 9 · 2019: 9 · 2018: 11 · 2017: 11 · 2016: 8 · 2015: 15 · 2014: 14 · 2013: 18 · 2012: 17
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- X-linked adrenoleukodystrophy, ABCD1 gene, oxidative stress, lipid peroxidation, glycoxidation, very long chain fatty acids, adrenomyeloneuropathy, antioxidant defense, Trolox, oxidative protein damage
- MeSH terms
- Superoxide Dismutase 2, Adrenoleukodystrophy, Animals, Catalase, Chromans, Fatty Acids, Fibroblasts, Humans, Lysine, Malondialdehyde, Mice, Inbred C57BL, Motor Neurons, Oxidation-Reduction, Spinal Cord, Superoxide Dismutase, Oxidative Stress, Mice, Membrane Potential, Mitochondrial, Chemokine CCL22, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.